Ferid Murad | Academic Influence

Ferid Murad's AcademicInfluence.com Rankings

Ferid Murad

Medical

#13

World Rank

#27

Historical Rank

#9

USA Rank

Pharmacology

#2

World Rank

#2

Historical Rank

#1

USA Rank

medical Degrees

Ferid Murad

Philosophy

#2221

World Rank

#3846

Historical Rank

#820

USA Rank

Logic

#768

World Rank

#1298

Historical Rank

#271

USA Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Ferid Murad's Degrees

Bachelors Chemistry DePauw University
Doctorate Medicine Case Western Reserve University

Why Is Ferid Murad Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Ferid Murad was an American physician and pharmacologist, and a co-winner of the 1998 Nobel Prize in Physiology or Medicine. Early life Ferid Murad was born in Whiting, Indiana, on September 14, 1936. His parents were Henrietta Josephine Bowman of Alton, Illinois, and Xhabir Murat Ejupi, an Albanian immigrant from Gostivar in present-day North Macedonia. who subsequently changed his name to John Murad after being processed at Ellis Island in 1913. His mother was from a Baptist family and ran away from home in 1935, aged 17, to marry his father, who was 39 and Muslim. Murad is the oldest of three boys. Murad and his brothers were raised as Catholics. He was later baptized an Episcopalian while in college. The family owned a small restaurant while Murad was growing up, and he spent his youth working at the family business.

(See a Problem?)

Ferid Murad's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. (1977) (1392)
Agonist‐Induced Endothelium‐Dependent Relaxation in Rat Thoracic Aorta May Be Mediated through cGMP (1983) (984)
Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. (1991) (933)
Cyclic GMP synthesis and function. (1987) (850)
Isoforms of nitric oxide synthase. Characterization and purification from different cell types. (1991) (843)
Cyclic guanosine monophosphate as a mediator of vasodilation. (1986) (811)
Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. (1977) (721)
Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. (1984) (625)
Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitrinergic signal transduction. (1992) (623)
Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation (1983) (612)
Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle (1993) (567)
Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. (1991) (566)
Novel effects of nitric oxide. (2003) (560)
Nitric oxide synthase in macula densa regulates glomerular capillary pressure. (1992) (548)
Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3',5'-phosphate by preparations from cardiac muscle and liver. (1962) (472)
Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. (1984) (453)
Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides. (1992) (438)
Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. (1978) (438)
Protein Nitration in Cardiovascular Diseases (2002) (376)
Nitric Oxide and Cyclic GMP in Cell Signaling and Drug Development (2006) (353)
Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase. (1991) (345)
Role of cyclic GMP in the action of heat-stable enterotoxin of Escherichia coli (1978) (338)
Nω-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation (1990) (308)
Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung. (1986) (288)
Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase. (1991) (280)
Regulation of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate levels and contractility in bovine tracheal smooth muscle. (1977) (279)
An activity in rat tissues that modifies nitrotyrosine-containing proteins. (1998) (276)
Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. (1992) (271)
NO, nitrotyrosine, and cyclic GMP in signal transduction. (2001) (266)
Regional distribution of EDRF/NO-synthesizing enzyme(s) in rat brain. (1990) (258)
Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP. (1983) (250)
Discovery of Some of the Biological Effects of Nitric Oxide and its Role in Cell Signaling (1999) (245)
Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system. (1994) (243)
Discovery of the nitric oxide signaling pathway and targets for drug development. (2009) (235)
Evidence for two different forms of guanylate cyclase in rat heart. (1974) (232)
Nitric Oxide and Cyclic GMP Signaling (1996) (231)
Protein Tyrosine Nitration in the Mitochondria from Diabetic Mouse Heart (2003) (229)
Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: a physiological regulator of guanosine 3',5'-monophosphate formation. (1977) (222)
Effects of sodium nitroprusside, nitroglycerin, and sodium azide on levels of cyclic nucleotides and mechanical activity of various tissues. (1977) (221)
Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. (1990) (218)
Vascular System: Role of Nitric Oxide in Cardiovascular Diseases (2008) (216)
Soluble guanylate cyclase from rat lung exists as a heterodimer. (1986) (214)
Cutting Edge: Targeted Disruption of the C3a Receptor Gene Demonstrates a Novel Protective Anti-Inflammatory Role for C3a in Endotoxin-Shock1 (2000) (211)
Discovery of Some of the Biological Effects of Nitric Oxide and its Role in Cell Signaling (1999) (206)
Colocalization of nitric oxide synthase and NADPH-diaphorase in the myenteric plexus of the rat gut (1992) (203)
Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. (1990) (197)
Activation of guanylate cyclase from rat liver and other tissues by sodium azide. (1975) (196)
Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in cultured endothelial cells. (1986) (196)
Ca2+/calmodulin-regulated nitric oxide synthases. (1992) (195)
Activation of intestinal guanylate cyclase by heat-stable enterotoxin of Escherichia coli: studies of tissue specificity, potential receptors, and intermediates. (1980) (195)
Immunohistochemical localization of guanylate cyclase within neurons of rat brain. (1982) (192)
Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. (2001) (187)
Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies. (1993) (187)
Properties and regulation of guanylate cyclase and some proposed functions for cyclic GMP. (1979) (185)
Regulation of nitric oxide and soluble guanylyl cyclase (2004) (185)
The nature of heme/iron-induced protein tyrosine nitration (2003) (166)
Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells. (1988) (166)
The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication. (1994) (163)
Stimulatory effects of atrial natriuretic factor on phosphoinositide hydrolysis in cultured bovine aortic smooth muscle cells. (1989) (159)
Effects of lipolytic and antilipolytic agents on cyclic 3',5'-adenosine monophosphate in fat cells. (1971) (159)
Engrafted bone marrow-derived flk-(1+) mesenchymal stem cells regenerate skin tissue. (2005) (153)
Biochemical Mechanisms Underlying Vascular Smooth Muscle Relaxation: The Guanylate Cyclase‐Cyclic GMP System (1988) (152)
Expression of soluble guanylate cyclase activity requires both enzyme subunits. (1991) (151)
Desensitization to nitroglycerin in vascular smooth muscle from rat and human. (1986) (150)
Calcium rather than cyclic AMP as the physiological intracellular regulator of prolactin release. (1980) (149)
A simple, sensitive protein-binding assay for guanosine 3':5'-monophosphate. (1971) (149)
Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. (2001) (148)
Nitric oxide signaling: would you believe that a simple free radical could be a second messenger, autacoid, paracrine substance, neurotransmitter, and hormone? (1998) (148)
Signal Transduction Using Nitric Oxide and Cyclic Guanosine Monophosphate (1996) (146)
Nitric oxide (NO): Biogeneration, regulation, and relevence to human diseases (2003) (143)
Nitric oxide : biochemistry, molecular biology, and therapeutic implications (1995) (140)
Ca2+/calmodulin-dependent NO synthase type I: a biopteroflavoprotein with Ca2+/calmodulin-independent diaphorase and reductase activities. (1992) (139)
Molecular cloning of a cDNA coding for 70 kilodalton subunit of soluble guanylate cyclase from rat lung. (1988) (137)
Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors (1993) (137)
Quantitative Protein Profiling in Heart Mitochondria from Diabetic Rats* (2003) (137)
Nitric oxide: a guardian for vascular grafts? (2011) (136)
Human recombinant soluble guanylyl cyclase: expression, purification, and regulation. (2000) (135)
Effect of In Vivo Nitroglycerin Therapy on Endothelium‐Dependent and Independent Vascular Relaxation and Cyclic GMP Accumulation in Rat Aorta (1987) (133)
Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development. (2006) (131)
Nitric oxide and cGMP signaling. (1995) (124)
Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immunoreactivity in proteins (2003) (122)
Comparison of binding and cyclic GMP accumulation by atrial natriuretic peptides in endothelial cells. (1986) (121)
Reversible inactivation of guanylate cyclase by mixed disulfide formation. (1981) (119)
Effects of cyclic GMP on smooth muscle relaxation. (1994) (117)
Increases in cyclic GMP levels in brain and liver with sodium azide an activator of guanylate cyclase (1975) (117)
Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate. (1972) (116)
Existence of nitric oxide synthase in rat hippocampal pyramidal cells. (1994) (115)
Purification and characterization of a human NO synthase. (1991) (111)
Atriopeptin II elevates cyclic GMP, activates cyclic GMP-dependent protein kinase and causes relaxation in rat thoracic aorta. (1985) (108)
Brain natriuretic factor Augmentation of cellular cyclic GMP, activation of particulate guanylate cyclase and receptor binding (1988) (108)
Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in N1E-115 neuroblastoma cells requires calcium and calmodulin. (1990) (108)
NO-cGMP Signaling and Regenerative Medicine Involving Stem Cells (2007) (105)
Nitric oxide synthase immunoreactivity and NADPH-diaphorase activity in a subpopulation of intrinsic neurones of the guinea-pig heart (1992) (104)
Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure. (1988) (104)
Sodium nitroprusside-induced protein phosphorylation in intact rat aorta is mimicked by 8-bromo cyclic GMP. (1982) (104)
Effect of thyrocalcitonin on adenosine 3':5'-cyclic phosphate formation by rat kidney and bone. (1970) (102)
Thiazide diuretics and calcium metabolism. (1973) (101)
Identification of an endothelial-like type III NO synthase in LLC-PK1 kidney epithelial cells. (1994) (101)
Colocalization of nitric oxide synthase and NADPH‐diaphorase in cultured myenteric neurons (1992) (101)
Stabilizing the cold plasma-stimulated medium by regulating medium’s composition (2016) (99)
Characterization of nitric oxide synthases in non‐adrenergic non‐cholinergic nerve containing tissue from the rat anococcygeus muscle (1991) (99)
Guanylyl cyclase is an ATP sensor coupling nitric oxide signaling to cell metabolism (2003) (96)
Characterization of ATP-stimulated guanylate cyclase activation in rat lung membranes. (1990) (96)
Effects of atrial natriuretic factor, sodium nitroprusside, and acetylcholine on cyclic GMP levels and relaxation in rat aorta. (1985) (96)
Effects of decapitation, ether and pentobarbital on guanosine 3',5'-phosphate and adenosine 3',5'-phosphate levels in rat tissues. (1974) (94)
Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells (2008) (92)
Endothelium-dependent and nitrovasodilator-induced activation of cyclic GMP-dependent protein kinase in rat aorta. (1983) (91)
Glyceryl trinitrate-induced desensitization of guanylate cyclase in cultured rat lung fibroblasts. (1988) (91)
Endothelial nitric oxide synthase is myristylated (1992) (90)
Two closely linked but separable promoters for human neuronal nitric oxide synthase gene transcription. (1995) (90)
Ligand Selectivity of Soluble Guanylyl Cyclase (2006) (90)
Effect of glucagon on rat heart adenyl cyclase. (1969) (90)
Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation. (1987) (88)
Downregulation of nitrovasodilator‐induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin‐1β (1996) (88)
The effect of gonadotropins on testicular adenyl cyclase. (1969) (88)
Requirements for heme and thiols for the nonenzymatic modification of nitrotyrosine. (1999) (87)
A simple and sensitive bioassay method for detection of EDRF with RFL-6 rat lung fibroblasts. (1991) (87)
Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents. (1995) (87)
Regulation of glycogen metabolism in polymorphonuclear leukocytes. (1970) (86)
Endothelium-dependent vasodilator-and nitrovasodilator-induced relaxation may be mediated through cyclic GMP formation and cyclic GMP-dependent protein phosphorylation. (1983) (85)
Role of cardiac atria in the human renal response to changing plasma volume. (1988) (84)
Mechanisms of Adenosine Triphosphate‐, Thrombin‐, and Trypsin‐induced Relaxation of Rat Thoracic Aorta (1984) (83)
Cyclic nucleotide levels in incubations of guinea pig trachea. (1974) (83)
Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: a role for alpha-actinin nitration. (2006) (82)
Two forms of guanylate cyclase in mammalian tissues and possible mechanisms for their regulation. (1975) (82)
Cellular signaling with nitric oxide and cyclic GMP. (1999) (81)
Effects of Glyceryl Trinitrate on Endothelium‐Dependent and ‐Independent Relaxation and Cyclic GMP Levels in Rat Aorta and Human Coronary Artery (1987) (81)
Characterization of the receptor for heat-stable enterotoxin from Escherichia coli in rat intestine. (1986) (81)
Effects of Na+,K+-pump inhibitors and membrane depolarizing agents on acetylcholine-induced endothelium-dependent relaxation and cyclic GMP accumulation in rat aorta. (1985) (80)
Effects of thiols, sugars, and proteins on nitric oxide activation of guanylate cyclase. (1979) (80)
Nitric oxide (NO)--biogeneration, regulation, and relevance to human diseases. (2003) (80)
Properties and oxidative regulation of guanylate cyclase. (1977) (79)
ANP relaxes bovine tracheal smooth muscle and increases cGMP. (1989) (77)
Relationship between biotransformation of glyceryl trinitrate and cyclic GMP accumulation in various cultured cell lines. (1989) (77)
Localization of particulate guanylate cyclase in plasma membranes and microsomes of rat liver. (1975) (77)
Characterization and localization of nitric oxide synthase in non‐adrenergic non‐cholinergic nerves from bovine retractor penis muscles (1992) (76)
Induced RAW 264.7 macrophages express soluble and particulate nitric oxide synthase: inhibition by transforming growth factor-beta. (1992) (75)
Nitric Oxide Accelerates the Recovery from Burn Wounds (2007) (74)
Role of cyclic‐GMP in Relaxations of Vascular mooth Muscle (1985) (73)
Adenyl cyclase activity in particles from fat cells. (1969) (72)
Assay of cyclic nucleotides by receptor protein binding displacement. (1974) (72)
Nitration of succinyl-CoA:3-oxoacid CoA-transferase in rats after endotoxin administration (2001) (72)
Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation. (1987) (71)
Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta (2011) (71)
Effect of Sodium‐Potassium Pump Inhibitors and Membrane‐Depolarizing Agents on Sodium Nitroprusside‐Induced Relaxation and Cyclic Guanosine Monophosphate Accumulation in Rat Aorta (1985) (70)
A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases. (2009) (68)
Atrial natriuretic factor and sodium nitroprusside increase cyclic GMP in cultured rat lung fibroblasts by activating different forms of guanylate cyclase. (1987) (68)
YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components (2001) (68)
Characterization of protein inhibitors of guanylate cyclase activation from rat heart and bovine lung. (1978) (67)
Increased particulate and decreased soluble guanylate cyclase activity in regenerating liver, fetal liver, and hepatoma. (1975) (67)
Soluble guanylyl cyclase: the nitric oxide receptor. (2005) (67)
Calcitonin gene-related peptide (CGRP)-induced cyclic AMP, cyclic GMP and vasorelaxant responses in rat thoracic aorta are antagonized by blockers of endothelium-derived relaxant factor (EDRF) (1991) (66)
Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways (2016) (66)
Nitrotyrosine formation with endotoxin-induced kidney injury detected by immunohistochemistry. (1999) (66)
Differential Effects of Cold Atmospheric Plasma in the Treatment of Malignant Glioma (2015) (65)
Cyclic GMP : synthesis, metabolism, and function (1994) (65)
Effects of guanosine 3',5'-monophosphate on glycerol production and accumulation of adenosine 3',5'-monophosphate by fat cells. (1970) (65)
Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells (1996) (64)
A constitutively activated mutant of human soluble guanylyl cyclase (sGC): Implication for the mechanism of sGC activation (2003) (63)
Generation and role of angiostatin in human platelets. (2003) (63)
Adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate: concentrations in Morris hepatomas of different growth rates. (1973) (62)
Nitric Oxide Synthase in Bovine Superior Cervical Ganglion (1993) (61)
Cigarette smoke activates guanylate cyclase and increases guanosine 3',5'-monophosphate in tissues. (1977) (60)
Effects of Nitric Oxide on Skin Burn Wound Healing (2008) (60)
The Endothelium-Dependent Nitric Oxide-cGMP Pathway. (2016) (59)
Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation. (2010) (59)
The 1996 Albert Lasker Medical Research Awards. Signal transduction using nitric oxide and cyclic guanosine monophosphate. (1996) (58)
Subcellular localization of guanylate cyclase. (1975) (58)
Purification of soluble guanylate cyclase from rat liver. (1979) (57)
Forskolin, phosphodiesterase inhibitors, and cyclic AMP analogs inhibit proliferation of cultured bovine aortic endothelial cells (1986) (56)
Diversity of endotoxin-induced nitrotyrosine formation in macrophage-endothelium-rich organs. (2001) (56)
NOS‐2 signaling and cancer therapy (2012) (55)
Differential expression of genes involved in cGMP-dependent nitric oxide signaling in murine embryonic stem (ES) cells and ES cell-derived cardiomyocytes. (2006) (55)
Pyridopyrimidine derivatives as inhibitors of cyclic nucleotide synthesis: Application for treatment of diarrhea (2008) (55)
Upregulation of S100 calcium‐binding protein A9 is required for induction of smooth muscle cell proliferation by a periodontal pathogen (2009) (54)
Effects of atriopeptin on particulate guanylate cyclase from rat adrenal. (1985) (54)
Atrial Natriuretic Factors Stimulate Accumulation and Efflux of Cyclic GMP in C6–2B Rat Glioma and PC12 Rat Pheochromocytoma Cell Cultures (1987) (53)
Purification and properties of a protein required for sodium azide activation of guanylate cyclase. (1977) (52)
Proteomic modification by nitric oxide. (2006) (52)
Intestinal receptor for heat-stable enterotoxin of Escherichia coli is tightly coupled to a novel form of particulate guanylate cyclase (1986) (52)
Induction of NADPH-dependent diaphorase and nitric oxide synthase activity in aortic smooth muscle and cultured macrophages. (1992) (52)
What are the molecular mechanisms for the antiproliferative effects of nitric oxide and cGMP in vascular smooth muscle? (1997) (52)
Formation of endothelium-derived relaxing factor in porcine kidney epithelial LLC-PK1 cells: an intra- and intercellular messenger for activation of soluble guanylate cyclase. (1991) (51)
Solubilization of guanylyl cyclase from bovine rod outer segments and effects of lowering Ca2+ and nitro compounds. (1991) (51)
Interactions of endothelins and EDRF in bovine native endothelial cells: selective effects of endothelin-3. (1992) (51)
Formation of adenosine 3':5'-monophosphate by preparations of guanylate cyclase from rat liver and other tissues. (1977) (49)
Estradiol rapidly inhibits soluble guanylyl cyclase expression in rat uterus. (2001) (49)
Nonenzymatic formation of guanosine 3':5'-monophosphate from guanosine triphosphate. (1974) (48)
Discovery of Some of the Biological Effects of Nitric Oxide and Its Role in Cell Signaling (Nobel Lecture). (1999) (48)
Cellular signaling with nitric oxide and cyclic guanosine monophosphate. (2000) (48)
α1 Soluble Guanylyl Cyclase (sGC) Splice Forms as Potential Regulators of Human sGC Activity* (2008) (47)
Vascular dilation by paeonol--a mechanism study. (2010) (47)
Endothelial cells have a particulate enzyme system responsible for EDRF formation: measurement by vascular relaxation. (1991) (46)
CCTη, a Novel Soluble Guanylyl Cyclase-interacting Protein* (2004) (46)
The involvement of catalytic site thiol groups in the activation of soluble guanylate cyclase by sodium nitroprusside. (1986) (46)
cGMP-dependent protein kinase activation in intact tissues. (1988) (45)
Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils. (1997) (44)
The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication. (1993) (43)
Appearance of magnesium guanylate cyclase activity in rat liver with sodium azide activation. (1976) (42)
Guanylate Cyclase: Regulation of Cyclic GMP Metabolism (1982) (42)
Differential expression of nitric oxide signaling components in undifferentiated and differentiated human embryonic stem cells. (2006) (41)
Regulation of guanylate cyclase by atrial natriuretic factor and the role of cyclic GMP in vasodilation. (1987) (41)
Down-regulation of inducible nitric-oxide synthase (NOS-2) during parasite-induced gut inflammation: a path to identify a selective NOS-2 inhibitor. (2001) (41)
Interaction of polymorphonuclear neutrophils with Escherichia coli. Effect of enterotoxin on phagocytosis, killing, chemotaxis, and cyclic AMP. (1978) (41)
Introduction and Some Historical Comments (1994) (40)
Nitric oxide-cyclic GMP signaling in stem cell differentiation. (2011) (40)
Conditions for the formation, partial purification and assay of an inhibitor of adenosine 3',5'-monophosphate. (1969) (39)
What is next in nitric oxide research? From cardiovascular system to cancer biology. (2014) (39)
Cyclic GMP: synthesis, metabolism, and function. Introduction and some historical comments. (1994) (39)
Increased urinary excretion of cyclic guanosine monophosphate in rats bearing Morris hepatoma 3924A (1975) (39)
Endothelin increases cyclic GMP levels in LLC-PK1 porcine kidney epithelial cells via formation of an endothelium-derived relaxing factor-like substance. (1991) (38)
NO-cGMP signaling in development and stem cells. (2006) (38)
Urinary excretion of cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate in rats bearing transplantable liver and kidney tumors. (1976) (38)
Expression of nitric oxide synthase isoforms and nitrotyrosine immunoreactivity by B‐cell non‐Hodgkin’s lymphomas and multiple myeloma (2001) (38)
LPS/IFN-γ-Induced RAW 264.7 Apoptosis is Regulated by Both Nitric Oxide–Dependent and –Independent Pathways Involving JNK and the Bcl-2 Family (2007) (37)
Sodium nitroprusside degenerates cultured rat striatal neurons. (1991) (37)
Novel pyridopyrimidine derivatives as inhibitors of stable toxin a (STa) induced cGMP synthesis. (2009) (36)
Effect of ouabain and alterations in potassium concentration on relaxation induced by sodium nitroprusside. (1983) (36)
Genomic organization of α1 and β1 subunits of the mammalian soluble guanylyl cyclase genes (2000) (35)
Production of an EDRF‐like activity in the cytosol of N1E‐115 neuroblastoma cells (1990) (35)
Endothelium-derived relaxing factor (EDRF): the endogenous activator of soluble guanylate cyclase in various types of cells (1989) (35)
Inhibition of Escherichia coli heat-stable enterotoxin by indomethacin and chlorpromazine (1980) (35)
Restoring Soluble Guanylyl Cyclase Expression and Function Blocks the Aggressive Course of Glioma (2011) (34)
N omega-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. (1990) (33)
CCAAT-binding factor regulates expression of the β1 subunit of soluble guanylyl cyclase gene in the BE2 human neuroblastoma cell line (2003) (33)
EDRF is an intracellular second messenger and autacoid to regulate cyclic GMP synthesis in many cells. (1990) (33)
Dynamic interplay between nitration and phosphorylation of tubulin cofactor B in the control of microtubule dynamics (2007) (33)
Evidence that nitric oxide mediates the cyclic GMP response to synaptic activity in the rat superior cervical ganglion (1992) (32)
Effect of cyanide on nitrovasodilator-induced relaxation, cyclic GMP accumulation and guanylate cyclase activation in rat aorta. (1984) (32)
Resonance Raman and infrared spectroscopic studies of high-output forms of human soluble guanylyl cyclase. (2005) (32)
Effects of atriopeptins on relaxation and cyclic GMP levels in human coronary artery in vitro. (1986) (32)
Requirement for a macromolecular factor for sodium azide activation of guanulate cyclase. (1975) (31)
Beta-blockade of epinephrine-induced cyclic AMP formation in heart, liver, fat and trachea. (1973) (31)
Myosin light chain phosphorylation in contraction and relaxation of intact rat thoracic aorta. (1986) (30)
The nitric oxide-cyclic GMP signal transduction pathway in vascular smooth muscle preparations and other tissues. (1992) (30)
Effects of nitrovasodilators, endothelium-dependent vasodilators, and atrial peptides on cGMP. (1988) (30)
Selective activation of particulate guanylate cyclase by a specific class of porphyrins. (1984) (30)
Curcumin induces differentiation of embryonic stem cells through possible modulation of nitric oxide-cyclic GMP pathway (2012) (30)
Regional differences in endothelin converting enzyme activity in rat brain: inhibition by phosphoramidon and EDTA (1992) (29)
Double-edged role of endogenous nitric oxide (1992) (29)
Nitric oxide and cyclic GMP signaling pathway as a focus for drug development. (2011) (29)
Adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate: a simultaneous protein binding assay. (1971) (28)
Atrial natriuretic peptide, oxytocin, and vasopressin increase guanosine 3',5'-monophosphate in LLC-PK1 kidney epithelial cells. (1988) (28)
Effects of atriopeptins on relaxation and cyclic GMP levels in rat and rabbit aortas. (1986) (28)
Properties of purified soluble guanylate cyclase activated by nitric oxide and sodium nitroprusside. (1982) (27)
Differentiation of Human Induced Pluripotent or Embryonic Stem Cells Decreases the DNA Damage Repair by Homologous Recombination (2017) (27)
Nitric Oxide: The Coming of the Second Messenger (2011) (26)
Lanthanum chloride inhibition of the secretory response to Escherichia coli heat-stable enterotoxin (1982) (26)
Stimulation of Inducible Nitric Oxide by Hepatitis B Virus Transactivator Protein HBx Requires MTA1 Coregulator* (2009) (26)
The placental cholinergic system: localization to the cytotrophoblast and modulation of nitric oxide (2006) (26)
Cold Plasma Accelerates the Uptake of Gold Nanoparticles Into Glioblastoma Cells (2015) (26)
Effect of GTP analogues on purified soluble guanylate cyclase. (1982) (26)
A simple, sensitive, and specific assay for the heat-stable enterotoxin of Escherichia coli. (1984) (26)
Nitric oxide and cyclic guanosine monophosphate signaling in the eye. (2008) (25)
Properties of guanylate cyclase from rat kidney cortex and transplantable kidney tumors. (1976) (25)
Cloning of Guonylyl Cyclase Isoforms (1994) (25)
Synthesis of adenosine 3',5'-monophosphate by guanylate cyclase, a new pathway for its formation. (1979) (24)
Mapping sites of tyrosine nitration by matrix-assisted laser desorption/ionization mass spectrometry. (2005) (24)
Atrial natriuretic peptides: Receptors and second messengers (1989) (24)
Purification of guanylyl cyclase from rod outer segments. (1991) (23)
Interrelationships of cyclic GMP, inositol phosphates, and calcium. (1994) (23)
sGC-cGMP signaling: target for anticancer therapy. (2014) (23)
Hydrogen Peroxide Alters Splicing of Soluble Guanylyl Cyclase and Selectively Modulates Expression of Splicing Regulators in Human Cancer Cells (2012) (22)
Generation of an endothelium-derived relaxing factor-like substance in bovine tracheal smooth muscle. (1991) (22)
Mechanism of vasculitis and aneurysms in Kawasaki disease: role of nitric oxide. (2003) (22)
Helminth regulation of host IL-4Ralpha/Stat6 signaling: mechanism underlying NOS-2 inhibition by Trichinella spiralis. (2005) (21)
Production and characterization of monoclonal antibodies to soluble rat lung guanylate cyclase. (1981) (21)
Role of cyclic GMP in the mechanism of action of nitrovasodilators, endothelium-dependent agents and atrial natriuretic peptide. (1988) (21)
Effects of ethacrynic acid and cystamine on sodium nitroprusside-induced relaxation, cyclic GMP levels and guanylate cyclase activity in rat aorta. (1988) (21)
High cyclic AMP levels in young chick embryonic hearts. (1975) (21)
Mass spectrometry-based relative quantification of human neutrophil peptides 1, 2, and 3 from biological samples. (2006) (20)
Nω-nitro-L-arginine : a potent inhibitor of the L-arginine-dependent soluble guanylate cyclase activation pathway in LLC-PK1 cells (1990) (20)
Cultured rat lung fibroblasts as a model for organic nitrate-induced cyclic GMP accumulation and activation of guanylate cyclase (1987) (20)
Some highlights of a 47 year career in research (2004) (20)
Nitric oxide signaling in vascular biology. (2007) (19)
Hormonal control of glycogen metabolism. (1979) (19)
Partial purification and characterization of particulate guanylate cyclase from rat liver after solubilization with trypsin. (1982) (19)
Anti-bacterial Activity of the Extract of Terminalia arjuna Against Multi Antibiotic Resistant Vibrio cholerae (2010) (18)
Effects of pyruvate and other metabolites on cyclic GMP levels in incubations of rat hepatocytes and kidney cortex. (1981) (18)
Immunolocalization of nitric oxide synthase isoforms in human archival and rat tissues, and cultured cells (2011) (18)
Atriopeptin-induced increases in endothelial cell permeability are associated with elevated cGMP levels. (1992) (17)
RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase. (2011) (17)
Guanylate cyclase and the adrenal natriuretic factor receptor. (1988) (17)
Human brain contains a metalloprotease that converts big endothelin‐1 to endothelin‐1 and is inhibited by phosphoramidon and EDTA (1992) (17)
Regulation of particulate guanylate cyclase by natriuretic peptides and Escherichia coli heat-stable enterotoxin. (1994) (16)
Anti-Inflammatory Effect of 1,3,5,7-Tetrahydroxy-8-isoprenylxanthone Isolated from Twigs of Garcinia esculenta on Stimulated Macrophage (2015) (16)
Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in normal children and those with cystic fibrosis. (1975) (16)
Regulation of Cyclic GMP Synthesis and the Interactions with Calcium (1986) (16)
Particulate and Soluble Bovine Endothelial Nitric Oxide Synthases Are Structurally Similar Proteins Yet Different from Soluble Brain Nitric Oxide Synthase (1992) (16)
Characterization of endothelin-converting enzyme from endothelial cells and rat brain: detection of the formation of biologically active endothelin-1 by rapid bioassay. (1992) (16)
Enhancing cold atmospheric plasma treatment of cancer cells by static magnetic field (2017) (15)
Genomic organization of alpha1 and beta1 subunits of the mammalian soluble guanylyl cyclase genes. (2000) (15)
Properties of guanylate cyclase in adult rat liver and several Morris hepatomas. (1976) (15)
Purified guanylate cyclase: characterization, iodination and preparation of monoclonal antibodies. (1980) (15)
Cyclic Nucleotides and Protein Phosphorylation in Vascular Smooth-Muscle Relaxation (1989) (14)
Mechanisms for Hormonal Regulation of the Different Isoforms of Guanylate Cyclase (1989) (14)
The excitement and rewards of research with our discovery of some of the biological effects of nitric oxide. (2003) (14)
Specific atrial natriuretic factor receptors mediate increased cyclic GMP accumulation in cultured bovine aortic endothelial and smooth muscle cells. (1985) (14)
Effect of Nitro-Compound Smooth Muscle Relaxants and Other Materials on Cyclic GMP Metabolism (1979) (14)
Inhibition of Escherichia coli heat-stable enterotoxin effects on intestinal guanylate cyclase and fluid secretion by quinacrine. (1982) (14)
Nitric oxide receptor soluble guanylyl cyclase undergoes splicing regulation in differentiating human embryonic cells. (2011) (14)
Transcription of the human neuronal nitric oxide synthase gene in the central nervous system is mediated by multiple promoters. (1995) (14)
Modulation of the Guanylate Cyclase -cGMP System by Vasodilators and the Role of Free Radicals as Second Messengers (1989) (13)
Organ sites of lipopolysaccharide-induced nitric oxide production in the anesthetized rat. (2001) (13)
Stem cells and cardiovascular tissue repair: Mechanism, methods, and clinical applications (2006) (13)
Cloning of guanylyl cyclase isoforms. (1994) (13)
The role of superoxide anion in the inhibitory effect of SIN-1 in thrombin-activated human platelet adhesion. (2010) (13)
Subcellular localization and regulation of the enzymes responsible for EDRF synthesis in endothelial cells and N1E-115 neuroblastoma cells (1990) (12)
Activation of liver guanylate cyclase by bile salts and contaminants in crude secretin and pancreozymin preparations. (1977) (12)
Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator. (2016) (12)
Fatty acid activation of guanylate cyclase from fibroblasts and liver. (1979) (12)
Resonance Raman and infrared spectroscopic studies of high-output forms of human soluble guanylyl cyclase (2005) (12)
nitric oxide synthases (1992) (12)
Free versus liposome-entrapped streptomycin sulfate in treatment of infections caused by Salmonella enteritidis. (1996) (12)
Role of Cyclic GMP in Endothelium-Dependent Relaxation of Vascular Smooth Muscle (1988) (11)
Enzymes Synthesizing Guanylate Cyclase-Activating Factors in Endothelial Cells, Neuroblastoma Cells, and Rat Brain (1991) (11)
Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoter (2011) (10)
Abstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications (2017) (10)
Separation of soluble adenylate and guanylate cyclases from the mature rat testis. (1979) (10)
A common antigenic determinant found in two functionally unrelated toxins (1984) (10)
Prolonged exposure to catecholamines enhances sensitivity of smooth muscle relaxation induced by sodium nitroprusside and atriopeptin. (1992) (10)
Effects of the JNK inhibitor anthra[1,9-cd]pyrazol-6(2H)-one (SP-600125) on soluble guanylyl cyclase alpha1 gene regulation and cGMP synthesis. (2005) (10)
Nitric oxide synthase in ferret brain: localization and characterization (1992) (9)
Quantification of guanylate cyclase concentrations by a direct double determinant tandem immunoradiometric assay. (1983) (9)
High-level expression of biologically active soluble guanylate cyclase using the baculovirus system is strongly heme-dependent. (1995) (9)
Epigenetic regulation of soluble guanylate cyclase (sGC) β1 in breast cancer cells (2016) (9)
Science Over Politics (1999) (8)
Cyclic GMP in Metabolism: Interrelationship of Biogenic Amines, Hormones, and Other Agents (1978) (8)
Nitric Oxide Signaling and Neural Stem Cell Differentiation in Peripheral Nerve Regeneration (2010) (8)
Refractoriness of toad bladder to stimulation of sodium transport. (1972) (8)
The Nitric Oxide Signal Transduction System (1995) (8)
A two-step procedure for obtaining highly purified particulate guanylate cyclase from rat lung. (1985) (8)
Medical Principles and Practice (2013) (8)
Identification of atrial natriuretic peptide receptors in cultured cells. (1991) (8)
Angiotensin (5–8) modulates nociception at the rat periaqueductal gray via the NO–sGC pathway and an endogenous opioid (2013) (8)
The Relaxant Activity of 4,7-Dimethyl-1,2,5-oxadiazolo[3,4-d]-pyridazine 1,5,6-Trioxide in the Mouse Corpus Cavernosum (2006) (7)
Guanylate cyclase: purification, properties, free radical activation, radiolabeling, and preparation of hybridoma antibodies. (1981) (7)
A hypothesis about cellular signaling with nitric oxide in the earliest life forms in evolution. (2009) (7)
Detection by Bioassay and Specific Enzyme‐Linked Immunosorbent Assay of Phosphoramidon‐Inhibitable Endothelin‐Converting Activity in Brain and Endothelium (1992) (7)
Mechanism of action of some bronchodilators. Cyclic nucleotide metabolism in tracheal preparations. (1974) (7)
Hormonal Regulation of the Different Isoforms of Guanylate Cyclase: EDRF Is a Ubiquitous Activator of Soluble Guanylate Cyclase1 (1990) (6)
Immunoaffinity purification of soluble guanylyl cyclase. (1991) (6)
Studies on Glycogen Synthase and Its Control by Hormones (1974) (6)
Aminophylline Potentiates Sodium Nitroprusside induced Hypotension in the Dog (1984) (6)
Endothelin-1 stimulates cyclic GMP formation in porcine kidney epithelial cells via activation of the L-arginine-dependent soluble guanylate cyclase pathway. (1991) (6)
Characterization and purification of a rat brain enzyme which catalyzes the formation of an EDRF-like factor from L-arginine (1990) (6)
Discovery of nitric oxide and cyclic GMP in cell signaling and their role in drug development (2012) (6)
Regulation of particulate guanylate cyclase by atriopeptins: relation between peptide structure, receptor binding, and enzyme kinetics. (1989) (5)
Isoforms of Nitric Oxide Synthase and the Nitric Oxide-Cyclic Gmp Signal Transduction System (1993) (5)
Molecular cloning of a regulatory protein for membrane-bound guanylate cyclase GC-A. (2000) (5)
Hormaonal regulation of cyclic AMP. (1973) (5)
Identification of two binding sites for atrial natriuretic factor in endothelial cells: evidence for a receptor subtype coupled to guanylate cyclase. (1986) (5)
The cytosol of N1E-115 neuroblastoma cells synthesizes an EDRF-like substance that relaxes rabbit aorta (1989) (5)
Isoforms of Nitric Oxide Synthase and the Nitric Oxide-Cyclic Gmp Signal Transduction System (1993) (5)
Guanylate cyclase activity in rat liver and other tissues with starvation and streptozotocin-induced diabetes mellitus. (1979) (4)
Ferid Murad, MD, PhD: a conversation with the editor. (2004) (4)
Automated "Gamma-flo" radioimmunoassay of urinary cyclic AMP. (1980) (4)
Modulating cGMP levels as therapeutic drug targets in cardiovascular and non-cardiovascular diseases (2014) (4)
Radiation inactivation target-size analysis of soluble guanylate cyclase. (1990) (3)
John Mendelsohn: A visionary scientist, oncologist and leader (2019) (3)
Mechanism of bradykinin-induced cyclic GMP accumulation in bovine tracheal smooth muscle (2004) (3)
Nitric Oxide Cell Signaling Mediated by cGMP (2005) (3)
Nobel laureates' letter to President Bush. (2001) (3)
Mechanisms of tolerance to sodium nitroprusside in cultured rat aortic smooth muscle cells (SMC) (1996) (2)
Development of mono clonal antibodies to soluble guanylate cyclase from rat lung (1981) (2)
N omega-nitro-L-arginine: a potent inhibitor of the L-arginine-dependent soluble guanylate cyclase activation pathway in LLC-PK1 cells. (1990) (2)
NO news is not necessarily good (1999) (2)
Copurification of atrial natriuretic peptide receptor and particulate guanylyl cyclase. (1991) (2)
Highly purified particulate guanylate cyclase from rat lung: characterization and comparison with soluble guanylate cyclase (2004) (2)
Discovery of nitric oxide and cyclic GMP in cell signaling and their role in drug development (2012) (1)
NO-cGMP signalling and cancer therapy (2013) (1)
Bioassay for EDRF/NO by accumulation of cyclic GMP in RFL-6 fetal rat lung fibroblasts (1992) (1)
Subject Index Vol. 31, 1980 (1980) (1)
Protective Effect of Type I Collagen Antisense Oligonucleotides on Bleomycin Induced Pulmonary Fibrosis (2010) (1)
Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein-HBx requires MTA1 coregulator. (2017) (1)
2745 – EFFECT OF NITRO-COMPOUND SMOOTH MUSCLE RELAXANTS AND OTHER MATERIALS ON CYCLIC GMP METABOLISM (1978) (1)
Tadalafil: Protective Action against the Development of Multiple Organ Failure Syndrome (2017) (1)
Comparison of particulate guanylate cyclase in cells with and without atrial natriuretic peptide receptor binding activity (1989) (1)
Heart of science (2011) (1)
Intestinal protein nitration induced by myeloperoxidase (2001) (1)
942 – SODIUM AZIDE ACTIVATION OF GUANYLATE CYCLASE (1977) (1)
Genetic silencing of sGC β1 in cancer: role of epigenetic regulation (2013) (0)
Reversible Inactivation Formation * of Guanylate Cyclase by Mixed Disulfide (0)
Increased expression of soluble guanylate cyclase (sGC) during the maturation of cultured CNS neurons (1991) (0)
NO-cGMP signalling and cancer therapy (2013) (0)
Nitric Oxide and Cyclic GMP Signaling in Cancer Therapy (2016) (0)
Ferid Murad, MD, PhD at 80: A Legacy of Science, Medicine, and Mentorship for their discoveries concerning nitric oxide as a signaling molecule in the cardiovascular system (2018) (0)
Protective Effects of NOS and/or sGC Inhibitors Combined with Antioxidant in LPS‐Induced Organ Dysfunction (2008) (0)
Enzymatic and non-enzymatic conversion of nitro-tyrosine and nitrated compounds (2000) (0)
ORGAN SITES OF LIPOPOLYSACCHARIDE (LPS) ‐ INDUCED NITRIC OXIDE (NO) PRODUCTION IN THE ANESTHETIZED RAT.: 230 (2001) (0)
Differentiation of human induced pluripotent or embryonic stem cells decreases the DNA damage response (2016) (0)
Cylic AMP. A mediator of hormone response and its clinical application. (1972) (0)
Techniques for the formation, partial purification, and assay of a cyclic AMP inhibitor. (1974) (0)
Regulation of soluble guanylate cyclase activity by direct interaction with heat shock protein Hsp90 (2005) (0)
Regional differences inendothelin converting enzyme activity in ratbrain: inhibition byphosphoramidon andEDTA (1992) (0)
New human alpha1 soluble guanylyl cyclase splice variants as potential regulators of sGC activity (2007) (0)
NO/cGMP Pathway in Diurnal Variations of Cardiac Function in Rats (2006) (0)
Vardenafil: a Phosphodiesterase-5 Inhibitor with protective action against the development of Multiple Organ Dysfunction Syndrome (MODS) (2014) (0)
A constitutively active heme-deficient mutant of human soluble guanylyl cyclase: implication for the mechanism of sGC activation (2003) (0)
Role of nitric oxide and cyclic GMP in proliferation and differentiation of murine and human embryonic stem cells (2005) (0)
Original Research Report Differential Expression of Nitric Oxide Signaling Components in Undifferentiated and Differentiated Human Embryonic Stem Cells (2006) (0)
Malondialdehyde (MDA): The Key Product In Lipid Peroxidation (2019) (0)
Atrial natriuretic factor receptor heterogeneity in rat tissues (1986) (0)
AFLUID July 46/1 (1999) (0)
Mechanisms oftolerance tosodium nitroprusside inratcultured aortic smooth muscle cells (1996) (0)
Study on NO/cGMP in Cell Signaling and Drug Development (2010) (0)
Three Dimensional Human Tissues as Surrogates for Research into Human Cellular Genomics, Proteomics, and Metabolomics During Suborbital Space Flight (2010) (0)
A Simple Molecule With a Complex Story (2006) (0)
Erratum: Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein-HBx requires MTA1 coregulator (Journal of Biological Chemistry (2010) 285 (6980-6986) DOI: 10.1074/jbc.M109.065987) (2017) (0)
DNA damage response decreases during induced pluripotent and embryonic stem cell differentiation (2016) (0)
CBF regulates expression of the β1 sGC gene in the BE2 human neuroblastoma cells (2003) (0)
thoracic aorta. Mechanisms of adenosine triphosphate-, thrombin-, and trypsin-induced relaxation of rat (2013) (0)
Nitrotyrosine formation with endotoxin-induced kidney injury detected by immunohistochemistry. (1999) (0)
A1164 VASOREACTIVITYINISOLATEDPERFUSED HUMAN LUNGS (1990) (0)
Mechanism of Action of Some Bronchodilators (2015) (0)
Soluble Guanylate Cyclase β1 Subunit Represses Human Glioblastoma Growth (2023) (0)
Activation of guanylate cylcase from fibroblasts and liver by fatty acids. Abstr. (1978) (0)
Gut mediated systemic down-regulation of nitric oxide synthase-2 expression (2000) (0)
Hypertension: Basics Concepts and the Evolving Role of Novel Treatments (2010) (0)
Hsp90 effects on the regulation of soluble guanylyl cyclase (2002) (0)
Dynamic ligand exchange as mechanism for sGC selectivity, NO activation and its reversal (2007) (0)
Curcumin induces differentiation of embryonic stem cells through possible modulation of nitric oxide-cyclic GMP pathway (2012) (0)
Abstracts of the 24th Annual Meeting of the Japan Neuroscience Society (2001) (0)
The preparation of 6x His-tagged granulocyte colony stimulating factor using an improved in vitro expression (2010) (0)
The roles of nitric oxide and cyclic GMP in signal transduction and vasodilation (1991) (0)
Nitric oxide cell signaling in cellular processes (2007) (0)
Genetic silencing of sGC β1 in cancer: role of epigenetic regulation (2013) (0)
Ca2+-channel protein nitration and intestinal smooth muscle contractility (2001) (0)
Dynamic interplay between nitration and phosphorylation of tubulin cofactor B in the control of microtubule dynamics (Proceedings of the National Academy of Sciences of the United States of America (2007) 104, 49, (19470-19475) DOI: 10.1073/pnas.0705149104) (2008) (0)
Soluble guanylyl cyclase is an ATP sensor coupling nitric oxide signaling to cell metabolism (2004) (0)
THE EFFECTS OF SODIUM NITROPRUSSIDE AND L-GLUTAMATE ON THE REGULATION OF THE CYTOSKELETAL ASSOCIATED PROTEIN TAU IN PRIMARY CULTURED NEURONS FROM RAT (1995) (0)
ANSWERING THE ACUTE QUESTION: HOW TO USE AMINOXYL (NITROXIDE) FREE RADICALS APPROPRIATELY TO REGULATE OXIDATIVE/NITROSATIVE STRESS AND AS POTENTIAL MEDICINES (2010) (0)
Subject Index (1965) (0)
Baculovirus-Mediated Highlevel Expression of a Functional Soluble Guanylyl Cyclase (1994) (0)
Experimental Study on the Neurological Basis for Systemic Inflammatory Response Syndrome (SIRS) Pathophysiology (2022) (0)
Contents Vol. 28, 2019 (2019) (0)
Contents Vol. 27, 2018 (2019) (0)
Abstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications (2017) (0)
Nitric oxide-releasing gel accelerates healing in a diabetic murine splinted excisional wound model (2023) (0)
Contents Vol. 29, 2020 (2020) (0)
Invited commentary (1977) (0)
Contents Vol. 30, 2021 (2021) (0)
Hydrogen peroxide regulates splicing by modulating the protein levels of select splice factors (2011) (0)
Genetic Diversity Has Prevailed, Not the Master Race (2010) (0)
Contents, Vol. 31, 1980 (1980) (0)

This paper list is powered by the following services:

Other Resources About Ferid Murad

en.wikipedia.org

What Schools Are Affiliated With Ferid Murad?

Ferid Murad is affiliated with the following schools:

Image Attributions

Image Source for Ferid Murad